The latest announcement is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A. announced the consensual termination of its CFO, Dr. Gianpiero Orlando, effective May 19, 2025. Dr. Orlando will continue his duties until then, including completing the preliminary activities for the 2024 fiscal year’s financial statements. The company will seek a replacement for the CFO role by the termination date, considering both internal and external candidates. The Related Parties Committee has approved the agreement, which includes a financial settlement for Dr. Orlando.
More about Fidia Spa
Fidia S.p.A. is a prominent company specializing in numerical control technology and integrated systems for computing, scanning, and milling complex shapes. It is listed on the Euronext Milan market and operates under the management of Borsa Italiana S.p.A.
Technical Sentiment Signal: Strong Sell
Current Market Cap: €929.8K
See more insights into FDA stock on TipRanks’ Stock Analysis page.